Introduction

R-loops
R-loops (RLs) are three-stranded nucleic acid structures that consist of a DNA:RNA hybrid and a displaced DNA strand [1] . Most RLs arise cotranscriptionally [2], although RL formation in trans has been documented in several cases [3, 4] . The main approach to evaluate RL levels is through DNA:RNA hybrid immunoprecipitation (DRIP), which utilizes the DNA:
RNA hybrid-specific monoclonal antibody S9.6 [5, 6] . Based on the various roles that RLs play, they were described as a 'double-edged sword', reflecting their capacity to lead to both beneficial and harmful cellular outcomes [7] . One of the clear physiological roles of RLs is facilitating class-switch recombination at the immunoglobulin heavy chain genes [8, 9] . However, DRIP-seq and DRIP followed by cDNA conversion Abbreviations AID, activation-induced cytidine deaminase; ALT, alternative lengthening of telomeres; DNMT, DNA methyltransferase; DRIPc, DRIP followed by cDNA conversion; DRIP, DNA:RNA hybrid immunoprecipitation; DSB, double strand break; ES, expression site; HR, homologous recombination; ICF, immunodeficiency, centromeric instability and facial anomalies; LCL, lymphoblastoid cell line; mRNPs, messenger ribonucleoproteins; RL, R-loop; RPA, replication protein A; S. cerevisiae, Saccharomyces cerevisiae; T. brucei, Trypanosoma brucei; TERRA, telomeric repeat-containing RNA; TRL, telomere R-loop; TSS, transcription start site.
(DRIPc)-seq analyses show that RLs form throughout many other genomic regions in various mammalian cell types, including normal primary cells [2, [10] [11] [12] . DNA regions that display strand asymmetry in the distribution of cytosines and guanines (GC skew) are predisposed to form RLs, especially when the C-rich strand serves as a template for transcription [2, 9] . Indeed, many of the sites at which RLs form are unmethylated CpG-rich promoters [2] , the majority of which display GC skew [13] . RLs were suggested at such promoters to prevent access to DNA methyltransferases (DNMTs) [2] , thus maintaining the promoters in an unmethylated, open chromatin state. A recent study clearly demonstrated that RLs promote transcription of over 1200 genes by blocking DNA methylation at promoters by DNMT1 [14] . RLs form also at regions of transcription termination [10] and were ascribed a role in promoting pause sites downstream to the polyadenylation signal as a step necessary for the release of the nascent RNA transcript [15, 16] . At the same time, both the DNA:RNA hybrids themselves, as well as the displaced single-stranded DNA, were implicated in various damaging activities that can lead to genomic instability (reviewed in detail in [1,7,17-19]). One mechanism by which RLs can induce damage is through replication fork stalling, which culminates in fork collapse followed by double strand breaks (DSB) and DNA loss ([20] , reviewed in [18] ). It has been proposed that replication fork progression may be blocked by RL-induced chromatin condensation [18] , as well as by G-quadruplexes [21, 22] that could form at the displaced single-stranded, G-rich DNA and stabilize the RLs (reviewed in [23, 24] ). The presence of RLs may also cause accumulation of mutations by subjecting the unpaired DNA strand to the action of enzymes such as activation-induced cytidine deaminase (AID) [25] .
Due to the potential threats they pose, RL levels are strictly regulated. Cellular mechanisms exist to prevent the formation of hazardous RLs, as well as to dismantle RLs that have formed. In this regard, because RLs are facilitated by the negative DNA supercoiling that arises during transcription, topoisomerases prevent generation of RLs by alleviating this topological strain [26] . In addition, efficient assembly of the nascent RNAs into messenger ribonucleoproteins (mRNPs) reduces the availability of the RNA to generate hybrids. Accordingly, the disruption of the THO/ TREX-2 complex, required to assemble and export mRNPs, leads to accumulation of genome wide RLs [27, 28] . The dismantling of RLs is carried out by RNA/DNA helicases that unwind the DNA:RNA hybrids [1] . Among others, these helicases include Pif1p, Sgs1/BLM, Sen1/Senetaxin, DHX9, and DDx21 [14, 16, [29] [30] [31] [32] [33] . RNase H1 and H2 which degrade the RNA component of the DNA:RNA hybrid also play an important role in removal of RLs [34, 35] . Additional means by which RLs are generated and dissolved have been recently reviewed [17] . Unscheduled RL formation and improper RL processing [18, 19, 36] have been linked to several human diseases including Fragile X syndrome [11, 37] , amyotrophic lateral sclerosis type 4, ataxia oculomotor apraxia type 2 [38] , Aicardi-Gouti eres syndrome [39] , and Angelman and Prader-Willi syndromes [40] .
A recent study carried out in Schizosaccharomyces pombe illustrated how different levels of RLs can lead to opposing outcomes ( [41] , reviewed in [42] ). This study demonstrated that DNA:RNA hybrids facilitate homologous recombination (HR) to promote repair of DSB. Resolution of hybrids by RNase H was found necessary to complete the DSB repair. Therefore, manipulation of RNase H levels that led to either excessive stabilization or destabilization of hybrids resulted in lack of repair, or excessive strand resection and DNA loss, respectively. This and other studies [36] emphasize the common theme that a delicate balance exists between the beneficial and the damaging levels of RLs. The final outcome of RL deregulation will depend on the genomic region at which RL perturbation occurs. A genomic region that has been the focus of RL study in the recent years is the telomere.
Telomeres
Telomeres, the ends of eukaryotic chromosomes, consist of DNA/RNA/protein complexes that protect the integrity and stability of chromosome extremities [43] [44] [45] [46] . A functional telomere prevents the DNA end of the chromosome from exposure to improper recombination or deleterious events such as degradation and end-to-end fusions [47] . Vertebrate telomeric DNA is composed of multiple (TTAGGG) repeats [48] that are packaged in a unique structure which is coated by shelterin and nonshelterin proteins [49] . In the absence of telomerase, a protein/RNA enzymatic complex that elongates the telomeric repeats by reverse transcription in germ cells and embryonic and adult stem cells [50, 51] , telomeric DNA gradually shortens during each cell division due to the 'end replication problem' [52] . When even a small subset of telomeres reaches a critical length, the cell enters replicative senescence and no longer divides [53] [54] [55] [56] . Cancer cells avoid replicative senescence by activating mechanisms that maintain telomere length. The majority of cancers activate the expression of the catalytic subunit of telomerase, hTERT, while the minority of cancers maintain telomeres by an alternative lengthening of telomeres (ALT) pathway that utilizes HR at telomeric regions [57] .
Telomeric regions are also characterized by specific histone modifications that contribute to the formation of a relatively compacted chromatin structure, which provides an additional layer of protection to telomeres [58] [64] , and Trypanosoma brucei (T. brucei) [65] . With exception of T. brucei, TERRA is transcribed by RNA polymerase II from subtelomeric promoters, and the telomeric C-rich leading strand serves as its template in all these organisms. The discovery of TERRA led to a myriad of studies exploring the possible function of this long noncoding RNA (most will not be addressed here and have been reviewed in [43] ).
Shortly after the discovery of TERRA, it was suggested that these long noncoding RNAs interact with telomeres through formation of DNA:RNA hybrids [66] . Telomeres constitute ideal regions for RL formation based on their sequence composition that displays complete GC-skewing and the fact that the TERRA transcripts are G-rich. Indeed, in the past 5 years telomeric R-loops (TRLs) have been described in several organisms. Next, we will review the current knowledge on TRLs in different organisms and several means by which TRLs are regulated. We will discuss how findings from yeast are relevant to human pathological scenarios in which TRLs are deregulated and address several open questions in the field.
Telomere R-loops in yeast
Several years following the discovery of TERRA in budding yeast [62], TRLs were described at telomeres of Saccharomyces cerevisiae (S. cerevisiae) [67] [68] [69] . The discovery of TRLs in S. cerevisiae provided a mechanistic explanation for the previously described phenomenon of induced HR at critically short telomeres in telomerase-negative cells [70] . Studies had shown that in the absence of telomerase, the majority of the population eventually enters senescence due to critically short telomeres [71, 72] in a manner dependent on transcription of TERRA [73] . However, rare survivors bypass senescence by lengthening their telomeres through RAD52-dependent recombination [74, 75] . The role of TRLs in mediating recombination at telomeres under these conditions was demonstrated in two independent studies [67, 69] and thus established a role for TERRA in induction of the type II ALT pathway through TRL formation. Modulating TRL levels clearly affected rates of recombination at telomeres: downregulation of TERRA, which reduces TRL levels, decreased levels of telomeric recombination in cis [67] , while upregulation of TERRA promoted recombination [69] . In concordance with the suggested role of TRLs, overexpression or suppression of RNase H repressed or induced telomeric recombination, respectively [67] . Interestingly, TRL accumulation and TRLrelated HR occur preferentially at short telomeres in telomerase-negative presenescent cultures, while long telomeres are not prone to TRL accumulation and HR-dependent elongation [67] . Thus, cells can avoid replicative senescence in the absence of telomerasebased maintenance by HR mediated through TERRAinduced TRLs.
While this beneficial outcome of TRL became evident, potential drawbacks of TRLs were anticipated as well. Telomeric DNA is challenging to replicate due to its repetitive nature and the unique T-loop structure that forms at telomere ends [76] . As RLs were shown to stall replication forks [20, 77] , their presence at telomeres could further impede replication and impair telomere integrity by leading to collapsed replication forks, resulting in DSB and loss of telomeric sequences. Accordingly, cells deploy various strategies to avoid undesirable levels of TRLs. In addition to RNase H1 and H2 [67] [68] [69] , the THO complex, involved in pre-mRNA processing and mRNA export, and also a component of telomeres in S. cerevisiae, was shown to play a role in suppressing TRLs [68, 69] . Helicases that unwind DNA:RNA hybrids throughout the genome also act to dismantle TRLs, as suggested specifically for Pif1 [29] .
A recent elegant study demonstrated how cell cycle regulation of TERRA provides an additional measure to avoid harmful effects of TRLs [78] . Since the majority of RLs were shown to form cotranscriptionally, eliminating TERRA during the stage at which telomeres are replicated would avoid the generation of TRLs and its associated replication stress. Graf et al. showed that TERRA is degraded primarily by Rat1 exonuclease prior to telomere replication, thereby preventing the generation of new TRLs. They also found that in parallel, Rif2 recruits RNase H2 to telomeres in order to degrade existing TRLs, leading to TRLs dissolution by the time that the replication fork proceeds through telomeres. However, this last finding seemed to contradict earlier studies demonstrating maintenance of critically short telomeres by TRL-induced HR in telomerase-negative cells [67] . Resolving this contradiction, Graf et al. [78] further showed that cell cycle control of TRLs is abolished in cells that carry critically short telomeres. Under these circumstances, TERRA preferentially accumulated at short telomeres, however TRLs were no longer removed from short telomeres prior to telomere replication, probably due to loss of Rif2, which normally recruits RNase H2, as was similarly demonstrated in [79] . The resulting persistence of TRLs during the stage of telomere replication activates the DNA damage response and recruits the recombination machinery that elongates the short telomeres. Thus, this study provided an explanation to why TRLs accumulate preferentially at short telomeres and shed light on how the cell cycle regulation of TERRA and TRLs oscillates according to the physiological needs related to telomere maintenance.
Telomere R-loops in the parasite
Trypanosoma brucei
Transcription from telomeric regions was first demonstrated in T. brucei. These transcripts originate from relatively internal subtelomeric expression sites (ESs) that produce the major surface antigen (VSG), whose switching enables evasion from the immune response of the host [80] . Under normal conditions, transcripts originating from subtelomeric ESs do not extend beyond a few kilobases, and therefore do not include the VSG regions nor the further 3 0 -downstream telomeric repeat regions. The transcription elongation is suppressed by TbRAP1, a telomere-binding protein [81] . A recent study demonstrated that depletion of TbRAP1 resulted in longer transcripts that do include telomeric repeats at their 3 0 end, and significantly elevated levels of RNase H-sensitive DNA:RNA telomeric hybrids [82] . No hybrids were detected using probes from the VSG locus, highlighting the specificity of hybrid formation at telomeric regions. These TRLs were associated with higher levels of DNA DSB, which triggered enhanced VSG switching by TRL-related recombination. Interestingly, while TERRA was transcribed from only one locus in TbRAP1-depleted cells, DSBs were detected at other VSG loci as well, suggesting that TRLs may form in trans in this organism. Thus, VSG switching in T. brucei is kept at low frequency, as required for its function, through strict control over TRL levels by TbRAP1 regulation of TERRA levels. TbRAP1 may also be involved in suppressing TRL generation or resolving TRLs [82] , and based on studies of other organisms, additional layers of protection may be expected to ensure the appropriate levels of TRLs under different physiological conditions.
Telomere R-loops in mammals
Telomere R-loops form in human cells
In mammalian cells, the discovery of TERRA sparked numerous studies on its modes of interaction with telomeres. Several studies demonstrated interaction of TERRA with proteins present at telomeres, both shelterin and non-shelterin [83, 84] . Although the telomeric repeat in humans varies from that in yeast, it similarly manifests a perfect GC-skewing, and is also transcribed from the C-rich leading strand [60, 61] . Thus, human TERRA was also predicted to associate with telomeric DNA by forming DNA:RNA hybrids as part of RLs. In line with this prediction, in vitro studies demonstrated that plasmids containing human telomeric repeats form RLs with telomere-containing RNA transcribed off the C-rich strand [85, 86] . Utilizing the S9.6-DNA:RNA hybrid-specific antibody, human TRLs were observed in cancer cells, in particular those that maintain their telomeres by the ALT pathway [85, 87, 88] , as well as in cells of patients with immunodeficiency, centromeric instability and facial anomalies (ICF) syndrome [86] . In both ALT and ICF cells, abnormally high levels of TERRA are transcribed [60, 85, [89] [90] [91] [92] , explaining the high levels of TRLs detected in these cells. However, TRLs are also found in normal human primary fibroblasts that transcribe low levels of TERRA, as shown by whole-genome DRIPseq [86] . As previously delineated by Rippe and Luke [93] , the outcome of TRLs is highly dependent on the state of the telomere: TRLs at short or damaged telomeres will lead to different activities in comparison to TRLs at normal telomeres. Extrapolating from the situation in yeast, the outcome of TRLs at short human telomeres is anticipated to depend on the presence of telomerase in the cells and the recombinogenic potential at chromosome ends. However, an inherent difference exists between yeast and human cells in their basic capacity to undergo recombination at telomeres, with telomeric recombination normally repressed in human cells (reviewed in [57, 94] ). Therefore, TRL-dependent recombination in human cells is only anticipated to occur in situations where additional mutations relieve the constraint on recombination at telomeres.
Do all human telomeres form R-loops?
Do all human telomeres have the potential to form TRLs, as found in yeast [67] ? Assuming that human TRLs play similar roles as those in S. cerevisiae, this question is relevant to whether or not all telomeres will be influenced, for good or for bad, in various cellular scenarios in which TRLs are involved. To answer this question, it must first be determined whether human TRLs form only in cis, or whether they can also form in trans (Fig. 1) . If they form only in cis, it is crucial to identify all the chromosome ends that transcribe TERRA and determine whether transcription alone is sufficient to drive TRL formation. If TRLs can form in trans as well, we must identify the destinations of TERRA molecules.
The binding of TERRA to telomeres in cis is supported by several lines of evidence in yeast [62, 67, 95] as well as in human cells [85, 86, 96] . Therefore, identifying the telomeres that transcribe TERRA should inform us which telomeres are potentially capable of generating TRLs. However, the source of TERRA is a matter of debate, as conflicting studies have reported that TERRA is transcribed from all human telomeres, from only a subset, or even from only one or two chromosome ends (recently reviewed in [97] ). Nevertheless, the majority of studies support the notion of TERRA being expressed from many human telomeres, albeit not all. Can we therefore expect that only the telomeres expressing TERRA will generate RLs? RL formation in trans has been reported in yeast, albeit not at telomeres (reviewed in [98] ). While it is still unknown how transcript invasion takes place in trans, this scenario at telomeres cannot be excluded, as the hexameric repeats shared by all telomeres could potentially allow TERRA produced at one telomere to interact with another chromosome end (Fig. 1) . Support to the possibility that TRLs form in trans comes from the very recent study by Lee et al. [99] which showed in vitro that the shelterin component TRF2 acts to generate TRLs by promoting TERRA invasion at telomeres. The N-terminal acidic domain of the additional shelterin protein, TRF1, blocked this activity and accordingly, reducing TRF1 levels in mammalian cells increased TRL levels. These findings suggest that TRF2 may be involved in generating TRLs with TERRA from other chromosome ends, especially when TRF1 activity is compromised. The relatively slow pace of the replication fork advancement at telomeric regions [100, 101] may also allow more opportunity for TERRA to invade these regions and anneal in trans. To date, there is no evidence in human cells for telomeric DNA:RNA hybrids forming with TERRA originating from another telomere. Resolving the question of TRL generation in trans awaits future experiments in which tracking the destination of a telomere-specific TERRA will be attainable.
How do subtelomeric regions contribute to TRL formation?
TERRA molecules initiate their transcription in the subtelomeric region and therefore include chromosome-specific subtelomeric sequences upstream to the telomeric repeat component [102] . Assuming that the majority of TRLs form cotranscriptionally, can we expect the subtelomeric component of TERRA to influence TRL formation? Most TERRA promoters are embedded in regions positioned within 2 kb of the telomere tract [86, 102, 103] , although TERRA promoters positioned 5-10 kb from the telomere tract have It is yet unknown whether the formation of telomere RLs occurs only cotranscriptionally (i.e., in cis) or whether a DNA:RNA hybrid at a certain chromosome end may be also formed with TERRA originating from different locations (i.e., in trans).
been described for several human telomeres [104] . Despite sharing high sequence similarity [105] , a bioinformatic analysis of the distal 2 kb of the majority of human chromosome ends revealed that subtelomeres differ in characteristics such as CpG richness, GC content, and GC-skewing [86] . In addition, this analysis indicated that a significant number of subtelomeres, but not all, possess positive GC skew immediately downstream to the putative transcription start site (TSS). These subtelomeric regions are therefore prone to form RLs, which may then extend into the adjacent telomeric repeat region [106] (Fig. 2A) .
A whole-genome DRIP-seq analysis carried out on human primary fibroblasts and on an embryonal carcinoma cell line indicated that many subtelomeres, and in particular those that display a strong positive GC skew, are enriched for DRIP signals [86] . For several subtelomeres, it was possible to pinpoint the DRIP-seq signals to the TERRA promoters and to the region between the TSS and the telomere tract. Thus, this analysis revealed that while many subtelomeres are capable of forming TRLs, certain subtelomeres are more prone to engage in hybrid formation.
The subtelomeric region component of most TERRA transcripts comprises up to several hundred nucleotides, while human TERRA molecules may reach in total several thousand nucleotides [60, 92] . By separating the telomeric tract from the subtelomeric region downstream to the TERRA promoter by restriction enzyme digestion, Sagie et al. demonstrated in human lymphoblastoid cell lines (LCLs) that the major DRIP signals originate from the telomeric repeat region of TERRA [86] . Despite comprising a relative minor part of the hybrid, the subtelomeres could still contribute to TRL generation based on their GC skew that would influence the efficiency of TRL seeding (Fig. 2B) . After initiating at subtelomeric regions, the TRL is expected to spread into the telomere-hexameric repeats, which constitute the majority of the TRL. The finding that not all telomeres generate TRLs equally suggests that human chromosome ends differ in their TRL-related outcome, whether beneficial or injurious, depending on the cellular context (Fig. 2B ).
Human TRLs in pathological context
In the following section, we will focus on TRLs in two pathological conditions in human cells: ICF syndrome and ALT cancers, and show how these two examples parallel the scenarios in telomerase-negative In most cases, TERRA is transcribed from promoters embedded in subtelomeric regions at close proximity to the telomeric repeats (blue triangles). TERRA anneals to the telomeric C-rich DNA strand, thus forming a DNA:RNA hybrid and displacing the G-rich strand. The 5 0 -end of TERRA that contains subtelomeric-specific sequence is part of the telomeric RL structure, but the hexameric repeats are predicted to comprise the majority of the TRL. The exact 3 0 -end of the hybrid cannot be determined due to the repetitive nature of the telomere. The degree of GC skew, depicted by the green shades in the lower bar, varies at different subtelomeres, but is high and constant along the telomere repeat region. (B) Although many subtelomeres share high sequence similarity, they differ in their levels of GC skew. TRL formation at a specific telomere is most likely influenced by the degree of subtelomeric GC skew as well as the levels of TERRA transcription in cis. If both GC skew and TERRA levels are high, as in telomere 2p, then the likelihood of TRL formation increases. A subtelomere with low GC skew and low TERRA transcription is unlikely to form a TRL (e.g., telomere 7q). The levels of TRLs formed at telomeres with high GC skew and low TERRA transcription (e.g., 16p) or conversely low GC skew but high TERRA transcription (e.g., 10p) are intermediate. However, the level of TERRA transcription is predicted to influence the degree of TRL formation more than the subtelomeric GC skew since the majority of the TRL forms at the repeat region.
S. cerevisiae cells, incapable vs capable of executing telomeric recombination. Through description of the findings in these pathological contexts, we will highlight the roles of RNase H and ATRX in safeguarding the telomere from the possible negative effects of human TRLs.
TRLs in ICF syndrome
Human TERRA promoters are highly methylated by DNMT3B [102, 107] , the DNMT responsible for de novo methylating repetitive regions during early embryonic development [108] . The methylation of TERRA promoters during development is intriguing, since they display typical CpG-rich promoter characteristics [102] , and such promoters are usually shielded from methylation during development (reviewed in [109] ). RLs were found to protect promoters from methylation by DNMTs both during development and in somatic cells [2, 14] . Therefore, low TERRA levels, and consequently, low TRL levels during the appropriate stages of development, could explain the permissiveness of TERRA promoters to de novo methylation. Future studies on TERRA transcription during early human embryonic development may assist in clarifying this point.
A clear positive correlation was established between TERRA and TRL levels in yeast [67] [68] [69] 78] . Normal human cells, in which TERRA levels are very low [86, 92, 110] , are unsuitable for studying whether a similar correlation exists in humans. However, ICF syndrome type I provides a powerful platform to study this correlation. Patients with this syndrome carry biallelic mutations in DNMT3B [108, 111] and accordingly, ICF cells present with drastically hypomethylated subtelomeres [91, 92, 110] . TERRA levels in ICF cells can reach 100-fold levels in comparison to wild-type cells [86] . Patient cells that either do not express telomerase, or express low levels of telomerase, display accelerated telomere shortening, and premature senescence [112] .
The finding that TERRA can induce telomere shortening in yeast and the discovery that TRLs mediate this shortening prompted the suggestion that a similar mechanism is responsible for the accelerated telomere shortening in ICF syndrome [67, 73] . The abnormally open chromatin configuration at telomeric regions in ICF cells [91] was additionally predicted to support generation of TRLs in these cells [93] . Subsequently, DRIP analysis conducted on a subset of telomeres in ICF LCLs confirmed this prediction. In a study by Sagie et al., [86] high TERRA levels and significantly elevated levels of TRLs were detected throughout the entire cell cycle in ICF cells (Fig. 3) . While this study did not prove unequivocally that TRLs form cotranscriptionally in ICF cells, this notion was supported by observing the levels of TRLs formed at various chromosome ends: It was found that the telomeres that substantially upregulated TERRA in ICF vs WT LCLs were also those that displayed the most pronounced TRL enrichment in ICF cells. In addition, the degree of GC skew calculated downstream to the putative TERRA TSSs segregated between the telomeres whose hybrid formation was affected in ICF cells and the telomeres that did not show elevated TRLs in ICF cells.
The outcome of TRLs in ICF cells
What is the outcome of the excessive TRLs in ICF cells? Similar to other genomic regions with high RLs [23], telomeres in ICF LCL display elevated levels of DNA damage, as detected by enhanced c-H2AX signals at telomeres. The relevance of this damage to TRLs was demonstrated by their sensitivity to RNase H1 [86] . Hence, these findings suggest that TRLs mediate, at least partially, the accelerated telomere shortening in ICF syndrome. Why don't TRLs promote telomere lengthening by HR in ICF cells? Most probably because ICF cells normally suppress recombination at telomeres [92, 110] . As such, ICF cells are comparable by many parameters to the S. cerevisiae est2 rad52 mutants that lack RNase H activity, and which were shown to critically shorten their telomeres and enter senescence [67] . Another aspect of the telomere pathology in ICF cells that mimics these mutant yeast cells is the nonlinear telomere shortening in ICF cells [106] comparable to the sudden telomere-loss events described in the yeast mutants [67] .
Is telomere loss stochastic in ICF cells?
In the est2 rad52 mutant S. cerevisiae cells, telomere loss occurs stochastically among the various chromosome ends [67] . Study of human cells supports the notion that telomeres differ in their capacity to instigate TRL formation based both on TERRA levels and on subtelomeric sequence. This suggests that certain telomeres are at a greater risk than others to shorten by a TRL-related mechanism. Sagie et al. have recently shown that shortening of telomeres in ICF LCLs is nonrandom with certain telomeres at greater risk to shorten [106] . The telomeres that belong to the shortest group of telomeres in ICF cells include many, but not all of those that were found to generate high TRL levels [86] . Future analysis of TRL formation at all chromosome ends is required to establish a firmer cause-and-effect relationship between TRLs and telomere shortening in ICF cells. We predict that while TRLs may contribute significantly to telomere shortening in this syndrome, their effect is probably integrated with additional influences related to compromised subtelomeric methylation.
Can ICF cells teach us whether short human telomeres are prone to generate TRLs?
In yeast, TERRA is expressed preferentially from short telomeres, leading to elevated TRL accumulation due to Rif2-regulated RNase H activity loss [78] . In ICF cells, the elevated TERRA transcription is unrelated to telomere length, but rather is due to the hypomethylated state of the TERRA promoters, as ICF fibroblasts immortalized with ectopic hTERT elongate their telomeres, and continue to express similar high levels of TERRA ( [92] and our unpublished results). Similarly, when induced pluripotent stem cells are generated from ICF fibroblasts, telomeres elongate but TERRA levels continue to be high [110] . Studying ICF cells in which telomeres are lengthened by ectopic hTERT which subsequently can be removed by CREmediated excision, will provide us with a suitable platform to explore the relation between telomere length and TRL generation in the absence of telomerase. Additionally, such a platform is predicted to indicate if telomerase plays a role in dampening TRL-related DNA damage at telomeres, as shown in telomerasepositive human cancer cells [85] . Since contrary to cancer cells, ICF cells display normal DNA damage checkpoints and resist recombination at telomeres, they provide a valuable system to identify the roles of TRLs in untransformed human cells.
TRLs in ALT cancer cells
The first human TRLs were described by Arora et al. [85] in ALT cancer cell lines, and this finding was later confirmed by additional studies [87, 88] . ALT cancers, which comprise approximately 15% of human cancers, are telomerase-negative and maintain their telomeres through HR [113] . In ALT cancer cells, elevated TERRA transcription, associated with reduced compaction of telomeric chromatin [89, 90] , leads to an increase in TRLs that are instrumental in facilitating recombination at telomeres [85] . A delicate balance of TRLs in ALT is crucial, and RNase H1 facilitates this regulation. Depleting RNase H1 results in TRL accumulation, replication stress, and rapid telomere shortening that is mediated by replication protein A (RPA)-related C-circle excision. In contrast, overexpression of RNase H1, which dismantles TRLs, causes gradual telomere shortening by reducing the potential of telomeres to lengthen by HR [85] . Telomeres in telomerase-positive cells are insensitive to changes in RNase H1 levels, probably because of their lower TERRA levels [89, 90] and because RNase H1 associates specifically with ALT telomeres [85] .
ATRX plays multiple roles in suppressing TRL-related recombination
In contrast to ICF cells that do not perform TRLrelated recombination, the repressed recombination between telomere sister chromatids is unleashed in ALT cancer cells due to mutations in ATRX and/or other genes responsible for this repression. ATRX, mutated in over 90% of ALT cancer cell lines [90] , is an ATP-dependent translocase belonging to the SWI/ SNF family of chromatin remodelers that forms a complex with the chaperone protein DAXX, and deposits the variant histone H3.3 at telomeric regions [114] . The role of ATRX in telomere maintenance may occur by several mechanisms, including cell cycle regulation of TERRA [115] (Fig. 4A) , RPA removal from telomeres following replication [115] (Fig. 4B) , telomere sister chromatid cohesion dissolution [116] ( Fig. 4C) , and disassembly of aberrant secondary structures, such as G-quadruplex structures, that arise due to replication fork stalling and can encourage HR at telomeres [117] (Fig. 4D) . Recently, it was demonstrated that the damaging secondary structures that ATRX acts to resolve are actually products of TRLs [88] . This study revealed that factors that influence TRL generation such as telomere length, repeat orientation, and TERRA transcription levels impact the degree by which ATRX is recruited to telomeres. Thus, it is apparent that ATRX binds preferentially in situations at which telomere maintenance is compromised due to abnormally high TRL levels. However, the mechanism by which ATRX suppresses the damaging secondary structures that TRLs generate is yet unclear. The unleashed recombination at telomeres in ALT cancers appears to be the consequence of multiple ATRX-related abnormalities that involve dysregulated TRLs. On one hand, elevated TERRA transcription, joined with ATRX-related loss of TERRA cell cycle regulation, creates a fertile ground for generation of TRL, as well as of secondary structures such as G-quadruplex structures [87] . On the other hand, ATRX loss prevents the dismantling of TRLs, and this leads to downstream events that instigate telomeric recombination. A TRL and G-quadruplex-dependent mechanism recently suggested for mediating telomere maintenance in ALT is spontaneous mitotic DNA synthesis. This response is elicited by DNA replication stress and executed in a Rad52-dependent, Rad51-independent manner [87] , reminiscent of the situation in telomerase-negative yeast cells that engage in Rad52-dependent recombination to lengthen critically short telomeres [67, 78] . The current studies showing TRL involvement in telomere maintenance in ALT cancers have been carried out on a limited number of cell lines, and future studies are necessary to determine the generality of this mechanism. The possibility that not all human telomeres generate TRLs raises the question of how all telomeres may be elongated through this mechanism in ALT cells. Resolving the issue of TRL generation in cis and/or in trans is in particular relevant if TRLs are indeed a major force that maintains telomeres in ALT cancers.
Do R-Loops form at mice telomeres?
Can mice serve as a model for studying TRLs in mammalian cells? Telomeric DNA:RNA hybrids in mice cells have not been reported to date. The extremely long telomeres of laboratory mice and the correlation found between telomere length and TRL formation [88] predict that in the presence of high TERRA levels, considerable levels of TRLs could form in mouse cells. On the other hand, northern blot analyses indicate that mice TERRA is much shorter than anticipated based on the extensive mice telomere length [61, 118] . Therefore, the contribution of the telomere length to potential TRLs in mice is questionable. The uncertainty related to TRL formation in cis and/or in trans is especially crucial when evaluating potential TRLs in mice. Reports related to the origin of TERRA have pointed to 18q as the major origin of TERRA production, with a small contribution from 9q and Xq ( [119] and recently reviewed in [97] ). Hence, if TRLs form solely or mainly in cis, TRLs are expected to be limited to one or very few chromosome ends. However, despite the very limited number of chromosome ends that transcribe TERRA, TERRA has been shown to associate in trans to various genomic regions in mice, including telomeres [60, 61, 84] . Thus, if TRLs may form in trans, many chromosome ends could potentially be candidates for TRL generation. Chu et al., also demonstrated that TERRA and ATRX interact in mice cells and TERRA and telomeric DNA compete for ATRX binding [84] . Thus, at situations in which abnormally high TERRA levels are transcribed, TRL levels would be enhanced (either in cis or in trans), but also ATRX binding to telomeres would theoretically be inhibited due to this competition. In such a case, TRLs would fail to be dismantled and this would lead to recombination at telomeres. Extrapolating this scenario to ALT cancer cells, it was suggested that upregulated TERRA levels would compete with ATRX binding to telomeres and thus eliminate ATRX action at telomeres [84] . Future probing of mice cells for the existence and location of TRLs will determine whether mice cells are a suitable platform from which we can draw conclusions related to human TRL biology.
Conclusions and future prospects
Several of the major unresolved questions related to TRLs may be addressed through the manipulation of TERRA from specific telomeres. Either activation of TERRA or its silencing at one or very few telomeres by genome-editing-related tools will be a productive avenue of research to determine whether TRLs are formed in cis, in trans, or both. Elucidating this aspect of TRL biology will assist in estimating the scope of chromosome ends affected by TRLs in scenarios of abnormally high TERRA transcription or deficiencies in TRL disassembly. However, the high sequence homology between human subtelomeres, and the limited knowledge regarding the accurate TSS of TERRA should be kept in mind. These factors will hamper the attempts to manipulate TERRA from specific chromosome ends. Nevertheless, when this obstacle is overcome, we will have the tools to determine whether certain telomeres are indeed more vulnerable than others to shortening due to elevated TRLs in cis, or whether when TERRA levels are high-all telomeres may form TRLs and be potentially affected. Manipulating TRLs in a fine-tuned manner may further enlighten us with regard to how TRL levels can switch abruptly from beneficial to damaging, and shed light on TRL-related telomere pathologies manifested in human diseases.
